Corona in general

A team of US-based scientists has recently explored various risk factors associated with the poor prognosis of coronavirus disease 2019 (COVID-19). They have identified thrombosis-related risk factors as a major predictor of in-hospital COVID-19 related mortality. // 14.12.2021

A new study, published on the medRxiv* preprint server, has aimed to determine if children's diet impacts the detection of SARS-CoV-2 virus in saliva. Scientists performed diagnostic tests to detect this virus using real-time self-collected specimens provided by five healthy children. // 14.12.2021

In a new study, the researchers assessed the spread of SARS-CoV-2 in golden Syrian hamsters to get a perspective on spatio-temporal conditions impacting the transmission efficiency of SARS-CoV-2 through the air. // 14.12.2021

This systematic review and meta-analysis evaluated the percentage of asymptomatic COVID-19 infections among individuals undergoing testing and those with confirmed infections. // 14.12.2021

Nature Medicine - A self-controlled case series using individual-patient-level data from over 38 million people aged 16 years and over, reveals an increased risk of myocarditis within a week of... // 14.12.2021

Antigenic drift refers to the evolutionary accumulation of amino acid substitutions in viral proteins selected by host adaptive immune systems as the virus circulates in a population. Antigenic drift can substantially limit the duration of immunity conferred by infection and vaccination. // 14.12.2021

Nature - The pairing of SARS-CoV-2 infection and vaccination against it confers powerful protection, but data from Israel show that that protection gradually declines. // 13.12.2021

A new study has been published in Frontiers in Immunology, where scientists developed a universal SARS-CoV-2 neutralizing antibody, MG1141A. // 13.12.2021

A new mouse study found that intranasal administration of MV130 protected against severe acute respiratory syndrome coronavirus 2. // 13.12.2021

A new study reports a method using four PCR tests to distinguish infection with the Omicron variant from that caused by other variants. // 12.12.2021

A new study demonstrates lethal infection of the olfactory epithelium in a mouse model that could help understand the mechanisms of COVID-19. // 12.12.2021

A new study aims to generate an understanding of the overall challenges that the people experiencing bereavement during the COVID-19 pandemic face. // 9.12.2022

America's hospitals, strained by nearly two years of fighting the covid-19 pandemic, are now scrounging for basic medical supplies. // 9.12.2021

New study findings indicate that antibody detection shows a distinct pattern depending on the type of antibody detected, the target antigen, the test design, antibody avidity level, and COVID-19 severity.

A review article focuses on the efficacy of neutralizing antibodies and vaccines against the SARS-CoV-2 variants. // 9.12.2021

Current evidence shows no improvement in survival and other important measures Convalescent plasma (a transfusion of blood plasma from someone who has recovered from covid-19) is not recommended for patients with covid-19, says a WHO Guideline Development Group of international experts in The BMJ today. Despite its initial promise, current evidence shows that it does not improve […] // 6.12.2021

New findings may help doctors choose effective COVID-19 treatment regimens for patients with heart complications. // 6.12.2021

Researchers hypothesize that a higher viral load of SARS-CoV-2 Delta variant in saliva contributes to its high transmissibility. // 6.12.2021

A recent modeling study published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) provides a quantitative framework for understanding the impact of drugs... // 6.12.2021

New surveillance data from South Africa published in the medRxiv* preprint server suggests that the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omnicron variant has the potential to escape naturally-acquired immunity. The research indicates people who previously recovered from a coronavirus disease 2019 (COVID-19) are at risk for reinfection with the Omicron variant. The results show that the risk of reinfection is greater with the Omicron variant versus Delta and Beta. // 6.12.2021

Researchers from Los Alamos National Laboratory in the United States developed a model to explain why severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections induce high inflammatory levels. // 6.12.2021

In a new study published in the bioRxiv* preprint server, researchers found that specific TCR sequences predicted the severity of coronavirus disease 2019 (COVID-19) infection. Additionally, there was evidence of increased CDR3 sequences and changes in k-mer motifs for patients with severe illness. // 6.12.2021

Evidence from a new study supports previous findings showing SARS-CoV-2 particles inside host cells are morphologically identical to those outside of cells. // 2.12.2021

Scientists have mined information from several research publications and patents to create a dataset of approximately 8000 human antibodies to the SARS-CoV-2 spike from more than 200 donors. // 2.12.2021

A new study has focussed on assessing the Mpro mutants of newly emerged SARS-CoV-2 variants. // 2.12.2021

Researchers from Academia Sinica in Taiwan have been investigating new antibodies that could have strong effects against SARS-CoV-2 infection. // 2.12.2021

Rinnakkaiselo virusten kanssa luo uusia tarpeita sekä rakenteille että rakennuksille. //

Brazilian researchers aim to determine the emergence and spread of the Delta VOC in different regions in Brazil. // 2.12.2021

A new trial showed that indoor live events are not associated with an increased risk of SARS-CoV-2 infection, provided preventive interventions are in place. // 2.12.2021

Researchers from Curtin University have formulated a new modeling framework to help identify the transmissibility of COVID-19 based on periods of varying case incidence. // 2.12.2021